Document is current
Any future updates will be listed below
-
Authors
Martin, Sebastian
Schreck, Moritz-Valentin
Stemler, Tobias
Maus, Stephan
Rosar, Florian
Burgard, Caroline
Schaefer-Schuler, Andrea
Ezziddin, Samer
Bartholomä, Mark D. https://orcid.org/0000-0002-0361-2833
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BA 3775/9-1, BA 3775/11-1)
Dr. Rolf M. Schwiete Stiftung
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 22 November 2024
First Online: 11 December 2024
Declarations
:
: Animal experimentations were conducted according to the protocols approved by the Veterinary Authorities of the Canton Vaud and in concordance with the Swiss Animal Welfare Act. Clinical PET imaging was performed on a compassionate use basis under the German Pharmaceutical Act §13 (2b). The patientGave his consent after being thoroughly informed about the risks and potential adverse effects of the application of [<sup>68</sup>Ga]Ga-<b>9</b> for PSMA PET/CT imaging.
: The patient agreed to the publication of the resulting data in accordance with the Declaration of Helsinki. All authors read and approved the final manuscript andGave their consent for publication.
: The authors declare that they have no competing interests.
